We supported the largest pharmaceutical family firm in Asia in designing and delivering a capacity-building training program for its key charity partners in China, post Takeda’s $60 billion purchase of Shire.

The program enhanced the family firm’s relationship with the local community in China and built up Takeda’s charity partners’ capacity in resource mobilization to create a sustainable impact on community health issues.